Liver cancer, particularly hepatocellular carcinoma (HCC), is a formidable health challenge that arises from complex biological mechanisms, including bile acid imbalance.Recent research highlights the critical role of the YAP signaling pathway in modulating liver disease mechanisms, indicating that disruptions in FXR function can exacerbate cancer risks.